Profund Advisors LLC Beam Therapeutics Inc. Transaction History

Profund Advisors LLC

$2.97 Billion
Q3 2025

A detailed history of Profund Advisors LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 30,046 shares of BEAM stock, worth $661,612. This represents 0.02% of its overall portfolio holdings.

Number of Shares

30,046

Previous 26,183 14.75%

Holding current value

$661,612

Previous $445,000 63.82%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	BUY	$16.01 - $25.1 $61,846 - $96,961	3,863 Added 14.75%	30,046 $729,000
Q2 2025 Aug 07, 2025	BUY	$14.54 - $20.24 $11,021 - $15,341	758 Added 2.98%	26,183 $445,000
Q1 2025 May 08, 2025	BUY	$19.53 - $34.09 $64,722 - $112,974	3,314 Added 14.99%	25,425 $496,000
Q4 2024 Feb 13, 2025	SELL	$21.55 - $30.35 $320,577 - $451,486	-14,876 Reduced 40.22%	22,111 $548,000
Q3 2024 Nov 13, 2024	BUY	$22.57 - $33.14 $138,105 - $202,783	6,119 Added 19.82%	36,987 $906,000

Q2 2024 Aug 13, 2024	SELL	$21.22 - $32.66 $164,836 - $253,702	-7,768 Reduced 20.11%	30,868 $723,000
Q1 2024 May 08, 2024	SELL	$23.46 - $45.07 $392,485 - $754,021	-16,730 Reduced 30.22%	38,636 $1.28 Million
Q4 2023 Feb 14, 2024	SELL	$17.69 - $30.76 $34,513 - $60,012	-1,951 Reduced 3.4%	55,366 $1.51 Million
Q3 2023 Nov 13, 2023	BUY	$23.01 - $32.46 $233,850 - $329,890	10,163 Added 21.55%	57,317 $1.38 Million
Q2 2023 Aug 10, 2023	BUY	$29.32 - $35.99 $218,346 - $268,017	7,447 Added 18.75%	47,154 $1.51 Million
Q1 2023 May 11, 2023	BUY	$30.15 - $48.79 $952,408 - $1.54 Million	31,589 Added 389.12%	39,707 $1.22 Million
Q4 2022 Feb 02, 2023	BUY	$36.73 - $51.6 $6,207 - $8,720	169 Added 2.13%	8,118 $317,000
Q3 2022 Nov 04, 2022	BUY	$39.79 - $70.31 $51,607 - $91,192	1,297 Added 19.5%	7,949 $379,000
Q2 2022 Aug 01, 2022	SELL	$29.86 - $62.36 $13,884 - $28,997	-465 Reduced 6.53%	6,652 $257,000
Q1 2022 May 10, 2022	SELL	$53.73 - $82.16 $42,984 - $65,728	-800 Reduced 10.1%	7,117 $408,000
Q4 2021 Feb 08, 2022	SELL	$68.02 - $99.06 $43,804 - $63,794	-644 Reduced 7.52%	7,917 $631,000
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $722,291 - $1.14 Million	8,561 New	8,561 $745,000

Others Institutions Holding BEAM

# of Institutions

249

Shares Held

95M

Call Options Held

888K

Put Options Held

549K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.55B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Beam Therapeutics Inc. Transaction History